Looking forward – what the future holds for precision medicine
Outlook for precision medicine.
According to a recent article in Medical Device & Diagnostic Industry, medical technology took big leaps forward in 2016. So whats in store for 2017?
Personalized Medicine
We are seeing a trend in personalization in every sector. One area that has seen a lot of progress is in the mapping of the human genome and the understanding of how individuals react to specific drug treatments. Increased technical power and understanding of the human genome is now allowing targeted therapy to become a reality.
With over more than 60% of patients failing to achieve remission with the first anti-depressant they are prescribed, personalized medicine is a big piece of the puzzle. Physicians and pharmacists can now review results from a simple no-cost buccal swab whether or not an individual can metabolize a medication, or may have drug interactions. Technology and the scope of personalized medicine will continue to grow and expand.
Government reimbursements for personalized medicine is one factor that is expected to propel the demand from 2016-2022.
There are three beneficiaries from the advancements of personalized medicine — patients, the pharmaceutical industry, and society. As developments are made in the field of personalized medicine, patients will receive safer and more effective treatment; the pharmaceutical industry will gain increased efficiency, productivity, and better product lines; and society will gain from decreased health care expenditures as a consequence of the more precise allocation of limited health care resources.
Pharmacogenetics is an emerging field that’s helping physicians make better prescription decisions. PGx Medical is the trusted and experienced resource for the implementation of pharmacogenetics in the field of aging services.
For more information on pharmacogenetics, contact: PGx Medical, info@pgxmed.com or 405-509-5112
References: MD&DI.com, managedcaremag.com,